BRIEF-Guizhou Xinbang Pharmaceutical sees FY 2018 H1 net profit up 20 pct to 50 pct

BRIEF-Guizhou

April 23 (Reuters) – Guizhou Xinbang Pharmaceutical Co Ltd

* Says it sees FY 2018 H1 net profit to increase by 20 percent to 50 percent, or to be 175.8 million yuan to 219.8 million yuan

* Says FY 2017 H1 net profit was 146.5 million yuan

* Comments that inclusion of new companies and increased profit of pharmacy and circulation business as main reasons for the forecast

Source text in Chinese:goo.gl/Vcagqy

Further company coverage: (Beijing Headline News)

Source Article